Cilostamide

This classification denotes a phosphodiesterase inhibitor with the molecular formula C20H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 45S5605Q18, chemically known as n-cyclohexyl-n-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide but generally known as cilostamide, which bears US NIH Compound Identifier 2753. European Medicines Agency schedules Cilostamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06272MIG. The term CILOSTAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). CILOSTAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cilostamide under HS 29337900 and SITC 51561. As of Q4 2014, CILOSTAMIDE remains the US FDA Preferred Term for this commodity. Cilostamide bears US NLM identifiers UMLS ID C0055728 and NCI Concept Code C76315. SMILES: O=C(N(C1CCCCC1)C)CCCOc1cc2c([nH]c(=O)cc2)cc1.